no code implementations • 31 Mar 2023 • Jianfeng Wu, Yi Su, Yanxi Chen, Wenhui Zhu, Eric M. Reiman, Richard J. Caselli, Kewei Chen, Paul M. Thompson, Junwen Wang, Yalin Wang
Objective: To build a surface-based model to 1) detect differences between APOE subgroups in patterns of tau deposition and hippocampal atrophy, and 2) use the extracted surface-based features to predict cognitive decline.
no code implementations • 22 Nov 2022 • Jianfeng Wu, Sijie Mai, Haifeng Hu
In this paper, we introduce Relation-dependent Contrastive Learning (ReCoLe) for inductive relation prediction, which adapts contrastive learning with a novel sampling method based on clustering algorithm to enhance the role of relation and improve the generalization ability to unseen relations.
no code implementations • 28 Oct 2022 • Jianfeng Wu, Yi Su, Wenhui Zhu, Negar Jalili Mallak, Natasha Lepore, Eric M. Reiman, Richard J. Caselli, Paul M. Thompson, Kewei Chen, Yalin Wang
Experimental results suggest that amyloid/tau measurements predicted with our PASCP-MP representations are closer to the real values than the measures derived from other approaches, such as hippocampal surface area, volume, and shape morphometry features based on spherical harmonics (SPHARM).
no code implementations • 20 Oct 2021 • Jianfeng Wu, Wenhui Zhu, Yi Su, Jie Gui, Natasha Lepore, Eric M. Reiman, Richard J. Caselli, Paul M. Thompson, Kewei Chen, Yalin Wang
We evaluate our framework on 925 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
1 code implementation • 17 Aug 2021 • Jianfeng Wu, Sijie Mai, Haifeng Hu
In this paper, we introduce Graph Capsule Aggregation (GraphCAGE) to model unaligned multimodal sequences with graph-based neural model and Capsule Network.
no code implementations • ICCV 2021 • Min Zhang, Yang Guo, Na lei, Zhou Zhao, Jianfeng Wu, Xiaoyin Xu, Yalin Wang, Xianfeng GU
Shape analysis has been playing an important role in early diagnosis and prognosis of neurodegenerative diseases such as Alzheimer's diseases (AD).
no code implementations • 26 Oct 2020 • Gang Wang, Qunxi Dong, Jianfeng Wu, Yi Su, Kewei Chen, Qingtang Su, Xiaofeng Zhang, Jinguang Hao, Tao Yao, Li Liu, Caiming Zhang, Richard J Caselli, Eric M Reiman, Yalin Wang
With hippocampal UMIs, the estimated minimum sample sizes needed to detect a 25$\%$ reduction in the mean annual change with 80$\%$ power and two-tailed $P=0. 05$ are 116, 279 and 387 for the longitudinal $A\beta+$ AD, $A\beta+$ mild cognitive impairment (MCI) and $A\beta+$ CU groups, respectively.
4 code implementations • 9 Feb 2020 • Razvan V. Marinescu, Neil P. Oxtoby, Alexandra L. Young, Esther E. Bron, Arthur W. Toga, Michael W. Weiner, Frederik Barkhof, Nick C. Fox, Arman Eshaghi, Tina Toni, Marcin Salaterski, Veronika Lunina, Manon Ansart, Stanley Durrleman, Pascal Lu, Samuel Iddi, Dan Li, Wesley K. Thompson, Michael C. Donohue, Aviv Nahon, Yarden Levy, Dan Halbersberg, Mariya Cohen, Huiling Liao, Tengfei Li, Kaixian Yu, Hongtu Zhu, Jose G. Tamez-Pena, Aya Ismail, Timothy Wood, Hector Corrada Bravo, Minh Nguyen, Nanbo Sun, Jiashi Feng, B. T. Thomas Yeo, Gang Chen, Ke Qi, Shiyang Chen, Deqiang Qiu, Ionut Buciuman, Alex Kelner, Raluca Pop, Denisa Rimocea, Mostafa M. Ghazi, Mads Nielsen, Sebastien Ourselin, Lauge Sorensen, Vikram Venkatraghavan, Keli Liu, Christina Rabe, Paul Manser, Steven M. Hill, James Howlett, Zhiyue Huang, Steven Kiddle, Sach Mukherjee, Anais Rouanet, Bernd Taschler, Brian D. M. Tom, Simon R. White, Noel Faux, Suman Sedai, Javier de Velasco Oriol, Edgar E. V. Clemente, Karol Estrada, Leon Aksman, Andre Altmann, Cynthia M. Stonnington, Yalin Wang, Jianfeng Wu, Vivek Devadas, Clementine Fourrier, Lars Lau Raket, Aristeidis Sotiras, Guray Erus, Jimit Doshi, Christos Davatzikos, Jacob Vogel, Andrew Doyle, Angela Tam, Alex Diaz-Papkovich, Emmanuel Jammeh, Igor Koval, Paul Moore, Terry J. Lyons, John Gallacher, Jussi Tohka, Robert Ciszek, Bruno Jedynak, Kruti Pandya, Murat Bilgel, William Engels, Joseph Cole, Polina Golland, Stefan Klein, Daniel C. Alexander
TADPOLE's unique results suggest that current prediction algorithms provide sufficient accuracy to exploit biomarkers related to clinical diagnosis and ventricle volume, for cohort refinement in clinical trials for Alzheimer's disease.